3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Nodule
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Recurrence
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroma
1
Neuralgia
1
Lymphoma, Follicular
1
Liver Metastasis Colon Cancer
1
Lipoma
1
Klatskin Tumor
1
Kidney Neoplasms
1
Hypesthesia
1
Esophageal Neoplasms
1
Cicatrix
1
Carcinoma, Hepatocellular
1
Bone Cancer Metastatic
1
Bile Duct Neoplasms
1
Agnosia
1
Adrenocortical Adenoma
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
6
cabozantinib
6
Nivolumab
5
Ipilimumab
5
Axitinib
5
Radiosurgery
3
Blood Specimen Collection
3
zimberelimab
2
lenvatinib
2
Ultrasonography
2
Radiotherapy
2
Biopsy
2
tislelizumab
1
polyethylene glycol 3350
1
pazopanib
1
palbociclib
1
orellanine
1
olaparib
1
gallium Ga 68 dotatate
1
fludarabine
1
cyclopropapyrroloindole
1
brodalumab
1
belzutifan
1
atezolizumab
1
anlotinib
1
adagrasib
1
Watchful Waiting
1
Vincristine
1
Therapeutics
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Kidney Neoplasms
×
Radiofrequency Ablation
×
Clear all
NCT06278506
2024-02-26
RESTART
Karolinska University Hospital
Phase NA
Recruiting
300 enrolled